Compensatory substitutions in the HCV NS3/4A protease cleavage sites are not observed in patients treated unsuccessfully with telaprevir combination treatment

BACKGROUND: Development of compensatory mutations within the HIV p7/p1 and p1/p6 protease cleavage site region has been observed in HIV-infected patients treated with protease inhibitors. Mechanisms of fitness compensation may occur in HCV populations upon treatment of HCV protease inhibitors as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, James C, Zhang, Eileen Z, Bartels, Doug J, Tigges, Ann, Dorrian, Jennifer L, Kwong, Ann D, Kieffer, Tara L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499439/
https://www.ncbi.nlm.nih.gov/pubmed/22866919
http://dx.doi.org/10.1186/1743-422X-9-147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499439/
https://www.ncbi.nlm.nih.gov/pubmed/22866919
http://dx.doi.org/10.1186/1743-422X-9-147

Ejemplares similares